8, 2023, Magalhes TR, Loureno AL, Gregrio H, Queiroga FL
- Video Overview A study published in the journal The BMJ found no significant increase in thyroid cancer risk for people with type 2 diabetes on GLP-1 agonists compared with people treated with DPP4 inhibitors
(QLD) If you have been told that managing Type 2 diabetes requires expensive, side-effect-laden medications for life, a groundbreaking new review just blew that myth apart
Peak weight loss on GLP-1 medications usually hits around the one-year mark, so this means most patients need to think in terms of 18 months or so from starting therapy to being ready for cosmetic facial work
Plasma Sci Technol 20(4):044007
It removes stubborn dark spots and blemishes